The effect of definity on systemic and pulmonary hemodynamics in patients

Kevin Wei, Michael L. Main, Roberto M. Lang, Allan Klein, Stephen Angeli, Carmelo Panetta, Issam Mikati, L. Veronica Lee, Jonathan A. Bernstein, Masood Ahmad

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

Original languageEnglish (US)
Pages (from-to)584-588
Number of pages5
JournalJournal of the American Society of Echocardiography
Volume25
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Pulmonary Artery
Hemodynamics
Lung
Blood Pressure
Vital Signs
Safety
Pressure
Pulmonary Wedge Pressure
Atrial Pressure
Cardiac Catheterization
Definity
Pulmonary Hypertension
Cardiac Output
Electrocardiography

Keywords

  • Contrast echocardiography
  • Hemodynamics
  • Pulmonary artery pressure
  • Safety

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

The effect of definity on systemic and pulmonary hemodynamics in patients. / Wei, Kevin; Main, Michael L.; Lang, Roberto M.; Klein, Allan; Angeli, Stephen; Panetta, Carmelo; Mikati, Issam; Lee, L. Veronica; Bernstein, Jonathan A.; Ahmad, Masood.

In: Journal of the American Society of Echocardiography, Vol. 25, No. 5, 05.2012, p. 584-588.

Research output: Contribution to journalArticle

Wei, K, Main, ML, Lang, RM, Klein, A, Angeli, S, Panetta, C, Mikati, I, Lee, LV, Bernstein, JA & Ahmad, M 2012, 'The effect of definity on systemic and pulmonary hemodynamics in patients', Journal of the American Society of Echocardiography, vol. 25, no. 5, pp. 584-588. https://doi.org/10.1016/j.echo.2012.01.019
Wei, Kevin ; Main, Michael L. ; Lang, Roberto M. ; Klein, Allan ; Angeli, Stephen ; Panetta, Carmelo ; Mikati, Issam ; Lee, L. Veronica ; Bernstein, Jonathan A. ; Ahmad, Masood. / The effect of definity on systemic and pulmonary hemodynamics in patients. In: Journal of the American Society of Echocardiography. 2012 ; Vol. 25, No. 5. pp. 584-588.
@article{eb2ae851d6304992b7e281e4bfc8b0ee,
title = "The effect of definity on systemic and pulmonary hemodynamics in patients",
abstract = "Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.",
keywords = "Contrast echocardiography, Hemodynamics, Pulmonary artery pressure, Safety",
author = "Kevin Wei and Main, {Michael L.} and Lang, {Roberto M.} and Allan Klein and Stephen Angeli and Carmelo Panetta and Issam Mikati and Lee, {L. Veronica} and Bernstein, {Jonathan A.} and Masood Ahmad",
year = "2012",
month = "5",
doi = "10.1016/j.echo.2012.01.019",
language = "English (US)",
volume = "25",
pages = "584--588",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - The effect of definity on systemic and pulmonary hemodynamics in patients

AU - Wei, Kevin

AU - Main, Michael L.

AU - Lang, Roberto M.

AU - Klein, Allan

AU - Angeli, Stephen

AU - Panetta, Carmelo

AU - Mikati, Issam

AU - Lee, L. Veronica

AU - Bernstein, Jonathan A.

AU - Ahmad, Masood

PY - 2012/5

Y1 - 2012/5

N2 - Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

AB - Background: The purpose of this study was to evaluate the pulmonary and systemic hemodynamic effects of Definity in patients with normal as well as those with elevated pulmonary artery pressure at baseline. Secondary objectives of the study were to evaluate safety and determine whether any potential immunologic reactions develop after Definity administration. Methods: Patients with normal and elevated pulmonary artery systolic pressure undergoing right-heart catheterization received Definity (10 μL/kg) as a slow bolus over 30 to 60 sec. Multiple sequential measurements of right atrial pressure, pulmonary artery systolic pressure, pulmonary artery diastolic pressure, mean pulmonary artery pressure, cardiac output, and pulmonary capillary wedge pressure were made before and after Definity administration. Vital signs, electrocardiograms, and blood samples were taken at multiple time points. Patients were followed for the development of adverse events. Results: A total of 32 patients (16 with elevated pulmonary artery systolic pressure > 35 mm Hg) were enrolled. No significant changes in any pulmonary or systemic hemodynamic parameters, vital sign values, electrocardiographic data, or laboratory variables were found for data obtained before versus after receipt of Definity. Conclusions: The administration of Definity at the approved dosage does not change pulmonary or systemic hemodynamics in control patients or those with mild to moderate pulmonary hypertension. No significant changes were noted in a wide array of clinical and laboratory safety assessments after patients were exposed to Definity.

KW - Contrast echocardiography

KW - Hemodynamics

KW - Pulmonary artery pressure

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=84860237550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860237550&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2012.01.019

DO - 10.1016/j.echo.2012.01.019

M3 - Article

VL - 25

SP - 584

EP - 588

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 5

ER -